MedPath

GEORGE CLINICAL PTY LTD

GEORGE CLINICAL PTY LTD logo
๐Ÿ‡ณ๐Ÿ‡ฟNew Zealand
Ownership
-
Employees
-
Market Cap
-
Website

Osteosarcoma Maintenance Therapy With OST31-164

Phase 2
Active, not recruiting
Conditions
Bone Cancer
Interventions
First Posted Date
2021-07-22
Last Posted Date
2025-01-22
Lead Sponsor
George Clinical Pty Ltd
Target Recruit Count
39
Registration Number
NCT04974008
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Kaiser Permanente Downey Medical Center, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Connecticut Children's, Hartford, Connecticut, United States

and more 18 locations

Dapagliflozin Treatment in Type 2 Diabetes

Phase 4
Completed
Conditions
Impaired Renal Function
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2020-11-09
Last Posted Date
2025-04-24
Lead Sponsor
George Clinical Pty Ltd
Target Recruit Count
17
Registration Number
NCT04620590
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CU Anschutz Medical Campus - Clinical Translational Research Center (CTRC), Aurora, Colorado, United States

๐Ÿ‡จ๐Ÿ‡ฆ

David Cherney, CM, PhD, Toronto, Ontario, Canada

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension

Completed
Conditions
Treatment Resistant Hypertension
First Posted Date
2017-03-13
Last Posted Date
2018-02-19
Lead Sponsor
George Clinical Pty Ltd
Target Recruit Count
1500
Registration Number
NCT03078244

Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung

Phase 2
Terminated
Conditions
Osteosarcoma
Metastatic Osteosarcoma
Interventions
First Posted Date
2013-01-03
Last Posted Date
2021-04-13
Lead Sponsor
George Clinical Pty Ltd
Target Recruit Count
12
Registration Number
NCT01759303
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

City of Hope, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic, Rochester, Minnesota, United States

and more 1 locations

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Phase 2
Completed
Conditions
Chondrosarcoma
Metastatic Chondrosarcoma
Interventions
First Posted Date
2011-04-07
Last Posted Date
2023-03-10
Lead Sponsor
George Clinical Pty Ltd
Target Recruit Count
47
Registration Number
NCT01330966
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic, Rochester, Minnesota, United States

๐Ÿ‡บ๐Ÿ‡ธ

City of Hope, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Edward Cancer Center, Naperville, Illinois, United States

and more 4 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath